Clinicopathological Analysis of Early-Stage Gastric Cancers Detected After Successful Eradication of Helicobacter pylori

Helicobacter

Volumn 16, Issue 3, 2011, Pages 210-216

  Yamamoto, Keiko ^a   Kato, Mototsugu ^b   Takahashi, Masakazu ^a   Haneda, Masahira ^a   Shinada, Keisuke ^a   Nishida, Urara ^a   Yoshida, Takeshi ^a   Sonoda, Norikazu ^a   Ono, Shoko ^b   Nakagawa, Manabu ^a   Mori, Yasuaki ^a   Nakagawa, Soichi ^a   Mabe, Katsuhiro ^a   Shimizu, Yuichi ^a   Moriya, Jun ^b   Kubota, Kanako ^b   Matsuno, Yoshihiro ^b   Shimoda, Tadakazu ^c   Watanabe, Hidenobu ^d   Asaka, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Eradication therapy; Gastric carcinoma; Helicobacter pylori; Mucin

Indexed keywords

BIOLOGICAL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; KI 67 ANTIGEN; MUCIN 2; MUCIN 5AC; MUCIN 6; PROTEIN P53; STOMACH MUCIN;

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; EARLY CANCER; ENDOSCOPIC SURGERY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME;

AGED; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 79956076042     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2011.00833.x     Document Type: Article

References (28)

1. Fukase K, Kato M, Inoue K, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet 2008;372:392-7.
2. Lorenzo F, Rocco MZ, Leonardo HE, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121-8.
3. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999;59:1003-7.
4. Ajioka Y, Watanabe H, Jass JR. MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J Clin Pathol 1997;50:417-21.
5. Tytgat KM, Buller HA, Opdam FJ, et al. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 1994;107:1352-63.
6. Endoh Y, Tamura G, Motoyama T, et al. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999;30:826-32.
7. Sato Y, Itoh F, Hinoda Y, et al. Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 1996;31:12-7.
8. Tsukashita S, Kushima R, Bamba M, et al. MUC gene expression and histogenesis of adenocarcinoma of the stomach. Int J Cancer 2001;94:166-70.
9. Mizoshita T, Tsukamoto T, Takenaka Y, et al. Gastric and intestinal phenotypes and histogenesis of advanced glandular stomach cancers in carcinogen-treated, Helicobacter pylori-infected Mongolian gerbils. Cancer Sci 2006;97:38-44.
10. Shiotani A, Nishi R, Noriya U, et al. Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer. Digestion 2010;81:223-30.
11. 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 1998;33:6-13.
12. Japanese Gastric Cancer Association office. First Department of Surgery, Kyoto Prefectural University of Medicine, Japan Gastric Cancer. 1998;1:10-24.
13. Watanabe H. The pathological sequence in the development of gastric cancer: II. Scand J Gastoenterol Suppl 1996;214:36-9.
14. Egashira Y, Simoda T, Ikegami M, et al. Mucin histochemical analysis of minute gastric differentiated adenocarinoma. Pathol Int 1999;49:55-61.
15. Tatematsu M, Katsuyama T, Furihara C, et al. Stable intestinal phenotypic expression of gastric and small intestinal tumor cells induced by N-methyl-N'-nitro-N-nitrosoguanidine or methylnitrosourea in rats. Gann 1984; 75:957-65.
16. Yamachica T, Inada K, Fujimatsu Y, et al. Intestinalization of gastric signet ring cell carcionomas with progression. Virchows Arch 1997;431:103-10.
17. Yoshikawa A, Inada K, Yamachika T, et al. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1998;1:134-41.
18. Wakatsuki K, Yamada Y, Narikiyo M, et al. Clinicopathological and prognostic significance of mucin phenotype in gastric cancer. J Surg Oncol 2008;98:124-9.
19. Kabashima A, Yao T, Nakanishi Y, et al. Relationship between biologic behavior and phenotypic expression in inrtamucosal gastric carcinomas. Hum Pathol 2002;33:80-6.
20. Shibata N, Watari J, Fujiya M, et al. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 2003;34:32-40.
21. Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 2001;61:212-20.
22. Shiroshita H, Watanabe H, Ajioka Y, et al. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains. Pathol Int 2004;54:311-21.
23. Tajima Y, Yamazaki K, Makino R, et al. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006;12:6469-79.
24. Sasaki A, Kitadai Y, Ito M, et al. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach. Oncology 2004;66:379-87.
25. Kushima R, Matsubara A, Kakinoki R, et al. Comparative histopathological study of H. plori-positive and negative gastric carcinomas. Stomach Intest 2007; 42:967-80.
26. Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci 2007;98:790-4.
27. Mizoshita T, Tsukamoto T, Toyoda T, et al. Intestinal phenotypes of stomach cancers arising after Helicobacter pylori eradication in carcinogen-treated Mongolian Gerbils. Asian Pac Cancer 2007;8:267-71.
28. Nisikura K, Watanabe H, Ajioka Y. Effect of Helicobacter pylori infection on carcinogenesis and development of gastric adenocarcinoma of differentiated type. Bacterial Adheren & Biofilm 2001;15:133-8.